Oligodendroglioma
About
Mappings
NCI Thesaurus: Oligodendroglioma (coding:ncit:C3288)
OncoTree: Oligodendroglioma, IDH-mutant, and 1p/19q-Codeleted (coding:oncotree:ODG)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | IDH1 p.R132C | Oligodendroglioma | Vorasidenib | |
| EMA (1) FDA (2) | IDH1 p.R132G | Oligodendroglioma | Vorasidenib | |
| EMA (1) FDA (2) | IDH1 p.R132H | Oligodendroglioma | Vorasidenib | |
| EMA (1) FDA (2) | IDH1 p.R132L | Oligodendroglioma | Vorasidenib | |
| EMA (1) FDA (2) | IDH1 p.R132S | Oligodendroglioma | Vorasidenib | |
| EMA (1) FDA (2) | IDH2 p.R172K | Oligodendroglioma | Vorasidenib | |
| EMA (1) FDA (2) | IDH2 p.R172M | Oligodendroglioma | Vorasidenib | |
| EMA (1) FDA (2) | IDH2 p.R172G | Oligodendroglioma | Vorasidenib | |
| EMA (1) FDA (2) | IDH2 p.R172S | Oligodendroglioma | Vorasidenib | |
| EMA (1) FDA (2) | IDH2 p.R172W | Oligodendroglioma | Vorasidenib |